Skip to main content
See every side of every news story
Published • loading... • Updated

Pharma: Boehringer Remains Independent - No IPO Planned

Despite billions of investments in research, Boehringer Ingelheim remains independent. Head of the company Deshpande wants to remain independent of external capital.

4 Articles

Lean Left

Here you will find information on the topic "Pharmaceuticals". Read now "Boehringer remains independent – no IPO planned".

·Germany
Read Full Article
volksfreund.devolksfreund.de
Reposted by
saarbruecker-zeitung.desaarbruecker-zeitung.de
Center

Despite billions of investments in research, Boehringer Ingelheim remains independent. Head of the company Deshpande wants to remain independent of external capital.

The pharmaceutical company Boehringer Ingelheim is one of the world leaders. CEO Shashank Deshpande explains why the family company still does not want to be listed on the stock market and what the placement of the family on the richest list means for its work.

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources are Center
67% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

manager magazin broke the news on Wednesday, September 30, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal